Trademarkia Logo

Canada

C$
LNJ
FORMALIZED

on 8 Aug 2024

Last Applicant/ Owned by

L&J BIO CO.LTD.

#711-712, A-dong, 128, Beobwon-ro,Songpa-guSeoul

KR

Serial Number

2342668 filed on 2th May 2024

LNJ

Trademark usage description

pharmaceutical preparations for the treatment of brain disease using technology capable of passing through the blood-brain barrier (bbb) to deliver th Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of brain disease using technology capable of passing through the blood-brain barrier (BBB) to deliver therapeutic proteins directly to brain tissue, using the DAT (dual action therapy) platform for medical purposes; pharmaceutical preparations for the treatment of Alzheimer's disease (senile dementia); pharmaceutical preparations for the treatment of brain disease for medical purposes; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of neurodegenerative brain diseases for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease.


Classification kind code

12

Mark Details


Serial Number

2342668

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 8th Aug 2024
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 8th Aug 2024
Formalized
Submitted for opposition 1
on 7th Aug 2024
Created
Submitted for opposition 30
on 2th May 2024
Filed
Submitted for opposition 228
on 2th May 2024
International Registration